Short Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Short Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Innovative Central Line Securement Device in the Pediatric Population [NA]
A pediatric trial evaluating an innovative central line securement device was terminated. Results were posted on July 5, 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Study of NST-6179 in Healthy Subjects [Phase 1]
Phase 1 study of NST-6179 in healthy subjects has been completed, with results posted. The trial evaluated safety and tolerability in the co…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Improved Quality of Life in Children With Intestinal Failure [NA]
A completed clinical trial reports improved quality of life in children with intestinal failure, including conditions such as short bowel sy…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases [NA]
A clinical trial evaluating the efficacy of umbilical cord blood mononuclear cells (UCB-MNCs) for refractory neonatal diseases, including hy…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older [Phase 3]
A Phase 3 clinical trial of teduglutide in Japanese children aged 4 months and older with Short Bowel Syndrome has completed, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Antithrombotic Management of Acute Mesenteric Ischaemia
The trial update notes completion of a study evaluating antithrombotic management in acute mesenteric ischemia (with short bowel syndrome as…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
Clinical trial update indicating the study evaluating level of deprivation in patients with short-bowel syndrome and intestinal failure has …
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition [Phase 4]
Phase 4 pharmacokinetics trial evaluating apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition.
-
FDA approval · 2024-02-21FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) to expand its indication for the management of short bowel syndrome. Th…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp [NA]
Clinical trial evaluating portable UVB lamp therapy for vitamin D deficiency in patients with short bowel syndrome has completed with posted…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS) [Phase 4]
A Phase 4 clinical trial evaluating growth hormone, glutamine, and diet in short bowel syndrome was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 [Phase 3]
Extension study update for teduglutide in Japanese participants with Short Bowel Syndrome after 24 weeks of prior treatment in related trial…
-
FDA approval · 2023-01-24FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Gattex (teduglutide) submitted by Takeda to modify/expand its labeling for the treatment of …
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome [Phase 2]
Phase 2 trial evaluating enteric-coated cholestyramine capsules for adults with short bowel syndrome; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302 [Phase 3]
Phase 3 trial update for SHP633-302 in Japanese children with Short Bowel Syndrome has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) [Phase 3]
A Phase 3 long-term safety and efficacy study of teduglutide in pediatric Short Bowel Syndrome completed, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Safety and Efficacy Study in Infant With SBS [Phase 2, Phase 3]
A safety and efficacy study in infants with Short Bowel Syndrome (Phase 2/3) was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study [Phase 3]
This updates the long-term study of teduglutide in pediatric patients with Short Bowel Syndrome following completion of the TED-C13-003 Phas…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome [Phase 3]
Phase 3 trial update on safety, efficacy and pharmacokinetics of teduglutide in 4- to 12-month-old infants with Short Bowel Syndrome; result…
-
FDA approval · 2021-02-11FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America. This action updates the dr…
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support [Phase 3]
Phase 3 clinical trial in Japanese pediatric subjects with short bowel syndrome who are dependent on parenteral support is completed and res…
-
FDA approval · 2021-01-29FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc., authorizing changes to its a…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Proof of Concept Study in Patients With Short Bowel Syndrome [Phase 1, Phase 2]
A proof-of-concept study in patients with Short Bowel Syndrome across Phase 1 and Phase 2 stages is ongoing, with current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Study of Teduglutide in Japanese Participants With Short Bowel Syndrome [Phase 3]
A Phase 3 clinical trial of teduglutide in Japanese participants with Short Bowel Syndrome has completed and results were posted in 2020.
-
FDA approval · 2020-07-14FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, updating the product labeling.